1. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray
    Zhongju Shi et al, 2017 CrossRef
  2. Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis
    Caijie Lu et al, 2017 CrossRef
  3. Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
    Jian Sun et al, 2017 CrossRef
  4. Telocinobufagin and Marinobufagin Produce Different Effects in LLC-PK1 Cells: A Case of Functional Selectivity of Bufadienolides
    Luciana Amaral et al, 2018, IJMS CrossRef
  5. Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma
    Raphael Berges et al, 2018, Cell Death Dis CrossRef
  6. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
    Chien-shan Cheng et al, 2019, Cancer Cell Int CrossRef
  7. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin
    Liping Chen et al, 2017, Pharmacological Research CrossRef
  8. lncRNA RMRP knockdown suppress hepatocellular carcinoma biological activities via regulation miRNA-206/TACR1.
    Zhao Hongfeng et al, 2020, J Cell Biochem CrossRef
  9. Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS
    Mengfei Han et al, 2020, Front. Oncol. CrossRef
  10. Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression.
    Jie Wang et al, 2018, Oncotarget CrossRef
  11. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
    Zhuo Yu et al, 2020, Cell Oncol. CrossRef
  12. Molecular mechanisms underlying the�antimetastatic activity of bufalin (Review)
    Jie Wang et al, 2018, mol clin onc CrossRef
  13. Cordyceps militaris fraction inhibits the invasion and metastasis of lung cancer cells through the protein kinase B/glycogen synthase kinase 3β/β‑catenin signaling pathway
    Qinqin Zhou et al, 2018, Oncol Lett CrossRef
  14. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
    Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef
  15. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2
    Pin Guo et al, 2020, J Exp Clin Cancer Res CrossRef
  16. Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics
    Xian Zhang et al, 2020, Am. J. Chin. Med. CrossRef
  17. Anticancer activities of TCM and their active components against tumor metastasis.
    Kailong Wang et al, 2021, Biomed Pharmacother CrossRef
  18. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms.
    Fang-Jie Li et al, 2021, Arch Pharm (Weinheim) CrossRef
  19. Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
    Xia Sheng et al, 2021, PRA CrossRef
  20. Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways.
    Mahshid Deldar Abad Paskeh et al, 2021, J Hepatocell Carcinoma CrossRef
  21. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment
    Xinshan Cao et al, 2019, oncol res CrossRef
  22. The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
    Han-yu Jiang et al, 2022, OTT CrossRef
  23. null
    Wanmi Sui et al, 2022 CrossRef
  24. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
  25. A research update on the antitumor effects of active components of Chinese medicine ChanSu
    Jinhao Jia et al, 2022, Front. Oncol. CrossRef
  26. Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
    Ammad Ahmad Farooqi et al, 2023, Molecules CrossRef
  27. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway
    Huhu Zhang et al, 2023, J Transl Med CrossRef
  28. Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis
    Huan Liu et al, 2024, Acta Pharmacol Sin CrossRef
  29. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling
    Xuemei Zhang et al, 2024, Phytomedicine CrossRef
  30. The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer
    Marta Zarzycka et al, 2024, Human Cell CrossRef
  31. Anti-Metastatic Effects of Standardized Polysaccharide Fraction from Diospyros kaki Leaves via GSK3β/β-Catenin and JNK Inactivation in Human Colon Cancer Cells
    Woo-Seok Lee et al, 2024, Polymers CrossRef
  32. Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives
    Yichao Liao et al, 2024, Front. Pharmacol. CrossRef
  33. Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway
    Nour Mhaidly et al, 2024, Cancers CrossRef
  34. Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential
    Xi Zhao et al, 2024, Heliyon CrossRef
  35. A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma
    Krishnapriya Ramakrishnan et al, 2025, Journal of Viral Hepatitis CrossRef
  36. Regulatory Mechanisms of Signaling Pathways in Liver Cancer Treatment with Traditional Chinese Medicine
    Shihao Zheng et al, 2025, Journal of Ethnopharmacology CrossRef